Page 1 | Search Results | Blood Advances | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Systemic bevacizumab for refractory bleeding and transfusion-dependent anemia in Heyde syndrome

Andrew B. Song, Rahul Sakhuja, Nancy M. Gracin, Ronald Weinger, Raj S. Kasthuri, Hanny Al-Samkari

Blood Adv (2021) 5 (19): 3850–3854.

https://doi.org/10.1182/bloodadvances.2021004810

Published: 2021

Journal Articles

Thrombosis and novel hemophilia therapies: the fine line between clotting and bleeding

Maureane Hoffman

Blood Adv (2021) 5 (18): 3736.

https://doi.org/10.1182/bloodadvances.2021004802

Published: 2021

Includes: Supplemental data

Journal Articles

Preclinical evaluation of immunotherapeutic regimens for fetal/neonatal alloimmune thrombocytopenia

Huiying Zhi, Maria T. Ahlen, Björn Skogen, Debra K. Newman, Peter J. Newman

Blood Adv (2021) 5 (18): 3552–3562.

https://doi.org/10.1182/bloodadvances.2021004371

Published: 2021

Includes: Supplemental data

Journal Articles

Continuous-infusion von Willebrand factor concentrate is effective for the management of acquired von Willebrand disease

Kathryn E. Dane, John P. Lindsley, Thomas Kickler, Michael B. Streiff, Alison Moliterno, Jennifer Yui, Rakhi Naik, Shruti Chaturvedi

Blood Adv (2021) 5 (14): 2813–2816.

https://doi.org/10.1182/bloodadvances.2021004843

Published: 2021

Journal Articles

Loss of the exocyst complex component EXOC3 promotes hemostasis and accelerates arterial thrombosis

Tony G. Walsh, Yong Li, Christopher M. Williams, Elizabeth W. Aitken, Robert K. Andrews, Alastair W. Poole

Blood Adv (2021) 5 (3): 674–686.

https://doi.org/10.1182/bloodadvances.2020002515

Published: 2021

Includes: Supplemental data

Journal Articles

Concizumab: a novel anti-TFPI therapeutic for hemophilia

Amy D. Shapiro

Blood Adv (2021) 5 (1): 279.

https://doi.org/10.1182/bloodadvances.2019001140

Published: 2021

Includes: Supplemental data

Journal Articles

von Willebrand factor variant D1472H has no effect in mice with humanized VWF-platelet interactions

Hannah K. Lohmeier, Tricia L. Slobodianuk, Sachiko Kanaji, Sandra L. Haberichter, Robert R. Montgomery, Veronica H. Flood

Blood Adv (2020) 4 (17): 4065–4068.

https://doi.org/10.1182/bloodadvances.2020002629

Published: 2020

Journal Articles

Cell interactions in the bone marrow microenvironment affecting myeloid malignancies

Konstantinos D. Kokkaliaris, David T. Scadden

Blood Adv (2020) 4 (15): 3795–3803.

https://doi.org/10.1182/bloodadvances.2020002127

Published: 2020

Journal Articles

The great platelet paradox: evolution of platelet contribution to hemostasis, inflammation, and thrombosis after injury

Matthew D. Neal

Blood Adv (2020) 4 (11): 2556.

https://doi.org/10.1182/bloodadvances.2019001166

Published: 2020

Includes: Supplemental data

Journal Articles

FVIII half-life extension by coadministration of a D′D3 albumin fusion protein in mice, rabbits, rats, and monkeys

Sabine Pestel, Hans-Wilhelm Beltz, Philipp Claar, Holger Lind, Marcel Mischnik, Elmar Raquet, Arna Andrews, Jason Simmonds, Vesna Tomasetig, Steven K. Dower, Anna Tjärnlund-Wolf, Stefan Schulte, Peter M. Schmidt, Thomas Weimer

Blood Adv (2020) 4 (9): 1870–1880.

https://doi.org/10.1182/bloodadvances.2019000999

Published: 2020

Includes: Supplemental data

Journal Articles

Coagulation factor XII contributes to hemostasis when activated by soil in wounds

Lih Jiin Juang, Nima Mazinani, Stefanie K. Novakowski, Emily N. P. Prowse, Martin Haulena, David Gailani, Leslie M. Lavkulich, Christian J. Kastrup

Blood Adv (2020) 4 (8): 1737–1745.

https://doi.org/10.1182/bloodadvances.2019000425

Published: 2020

Includes: Supplemental data

Journal Articles

Differential roles of factors IX and XI in murine placenta and hemostasis under conditions of low tissue factor

Steven P. Grover, Clare M. Schmedes, Alyson C. Auriemma, Emily Butler, Molly L. Parrish, Adam Miszta, Audrey C. Cleuren, Mayken Visser, Stefan Heitmeier, Jens J. Posma, Henri M. Spronk, Silvio Antoniak, Alisa S. Wolberg, Rafal Pawlinski, David Gailani, Nigel Mackman

Blood Adv (2020) 4 (1): 207–216.

https://doi.org/10.1182/bloodadvances.2019000921

Published: 2020

Includes: Supplemental data

Journal Articles

Analysis of factor V in zebrafish demonstrates minimal levels needed for early hemostasis

Angela C. Weyand, Steve J. Grzegorski, Megan S. Rost, Kari I. Lavik, Allison C. Ferguson, Marzia Menegatti, Catherine E. Richter, Rosanna Asselta, Stefano Duga, Flora Peyvandi, Jordan A. Shavit

Blood Adv (2019) 3 (11): 1670–1680.

https://doi.org/10.1182/bloodadvances.2018029066

Published: 2019

Journal Articles

Diacylglycerol kinase ζ is a negative regulator of GPVI-mediated platelet activation

Alyssa J. Moroi, Nicole M. Zwifelhofer, Matthew J. Riese, Debra K. Newman, Peter J. Newman

Blood Adv (2019) 3 (7): 1154–1166.

https://doi.org/10.1182/bloodadvances.2018026328

Published: 2019

Includes: Supplemental data

Journal Articles

Ontogeny of platelet function

Andreas Margraf, Claudia Nussbaum, Markus Sperandio

Blood Adv (2019) 3 (4): 692–703.

https://doi.org/10.1182/bloodadvances.2018024372

Published: 2019

Journal Articles

Prognostic value of D-dimer and markers of coagulation for stratification of abdominal aortic aneurysm growth

Alexandra C. Sundermann, Keith Saum, Kelsey A. Conrad, Hannah M. Russell, Todd L. Edwards, Kevin Mani, Martin Björck, Anders Wanhainen, A. Phillip Owens, III

Blood Adv (2018) 2 (22): 3088–3096.

https://doi.org/10.1182/bloodadvances.2017013359

Published: 2018

Includes: Supplemental data

Journal Articles

The endogenous antimicrobial cathelicidin LL37 induces platelet activation and augments thrombus formation

Maryam F. Salamah, Divyashree Ravishankar, Xenia Kodji, Leonardo A. Moraes, Harry F. Williams, Thomas M. Vallance, Dina A. Albadawi, Rajendran Vaiyapuri, Kim Watson, Jonathan M. Gibbins, Susan D. Brain, Mauro Perretti, Sakthivel Vaiyapuri

Blood Adv (2018) 2 (21): 2973–2985.

https://doi.org/10.1182/bloodadvances.2018021758

Published: 2018

Includes: Supplemental data

Journal Articles

Alterations in platelet secretion differentially affect thrombosis and hemostasis

Smita Joshi, Meenakshi Banerjee, Jinchao Zhang, Akhil Kesaraju, Irina D. Pokrovskaya, Brian Storrie, Sidney W. Whiteheart

Blood Adv (2018) 2 (17): 2187–2198.

https://doi.org/10.1182/bloodadvances.2018019166

Published: 2018

Includes: Supplemental data

Journal Articles

Dichloroacetate, an inhibitor of pyruvate dehydrogenase kinases, inhibits platelet aggregation and arterial thrombosis

Manasa K. Nayak, Nirav Dhanesha, Prakash Doddapattar, Omar Rodriguez, Vijay K. Sonkar, Sanjana Dayal, Anil K. Chauhan

Blood Adv (2018) 2 (15): 2029–2038.

https://doi.org/10.1182/bloodadvances.2018022392

Published: 2018

Includes: Supplemental data

Journal Articles

Factor XIII in plasma, but not in platelets, mediates red blood cell retention in clots and venous thrombus size in mice

Sravya Kattula, James R. Byrnes, Sara M. Martin, Lori A. Holle, Brian C. Cooley, Matthew J. Flick, Alisa S. Wolberg

Blood Adv (2018) 2 (1): 25–35.

https://doi.org/10.1182/bloodadvances.2017011890

Published: 2018

Includes: Supplemental data

NARROW

Systemic bevacizumab for refractory bleeding and transfusion-dependent anemia in Heyde syndrome

Thrombosis and novel hemophilia therapies: the fine line between clotting and bleeding

Preclinical evaluation of immunotherapeutic regimens for fetal/neonatal alloimmune thrombocytopenia

Continuous-infusion von Willebrand factor concentrate is effective for the management of acquired von Willebrand disease

Loss of the exocyst complex component EXOC3 promotes hemostasis and accelerates arterial thrombosis

Concizumab: a novel anti-TFPI therapeutic for hemophilia

von Willebrand factor variant D1472H has no effect in mice with humanized VWF-platelet interactions

Cell interactions in the bone marrow microenvironment affecting myeloid malignancies

The great platelet paradox: evolution of platelet contribution to hemostasis, inflammation, and thrombosis after injury

FVIII half-life extension by coadministration of a D′D3 albumin fusion protein in mice, rabbits, rats, and monkeys

Coagulation factor XII contributes to hemostasis when activated by soil in wounds

Differential roles of factors IX and XI in murine placenta and hemostasis under conditions of low tissue factor

Analysis of factor V in zebrafish demonstrates minimal levels needed for early hemostasis

Diacylglycerol kinase ζ is a negative regulator of GPVI-mediated platelet activation

Ontogeny of platelet function

Prognostic value of D-dimer and markers of coagulation for stratification of abdominal aortic aneurysm growth

The endogenous antimicrobial cathelicidin LL37 induces platelet activation and augments thrombus formation

Alterations in platelet secretion differentially affect thrombosis and hemostasis

Dichloroacetate, an inhibitor of pyruvate dehydrogenase kinases, inhibits platelet aggregation and arterial thrombosis

Factor XIII in plasma, but not in platelets, mediates red blood cell retention in clots and venous thrombus size in mice

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only